Unaudited Financial Results for the quarter ended on June 30, 2026.

8hcarat Parenterals Limited Registered Office & Works: Survey No.: 144-A, Jarod-Samlaya Road, Viii. Haripura. Ta. Savli, Dist. Vadodara - 391520 (Guj.) India. Mobile : 99099 28332 E-mail: info@bplindia.in, Web.: www.bplindia.in CIN NO:* L 24231 GJ 1992PLC018237 (WHO-GMP CERTIFIED STAR EXPORT HOUSE) Date: August 05, 2026 The Corporate Relationship Department BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai-400001. Script Code: 541096 SUB: OUTCOME OF THE BOARD MEETING. Dear Sir/Madam, Pursuant to Regulation 30, 33 and other related Regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and with reference to the captioned subject, we hereby inform that, the board of directors, at their meeting held today i.e. August 05, 2026 have inter-alia: 1. Approved and took on record the Un-audited Standalone and Consolidated Financial Results as per Indian Accounting Standards (IND AS) alongwith the Limited Review Report and Management Discussion and Analysis Report for the quarter ended June 30, 2026; 2. Fixed date of 33rd Annual General Meeting of the Member of the Company as Saturday, September 19, 2026, through Video Conferencing/other Audio-Visual means (VC/OAVM); 3. Approved the Notice of 33rd Annual General Meeting and Director's report along with Corporate Governance Report along with the annexure’s, Management Discussion Analysis Report and Auditor Report of the Company. 4. Approve the Re-appointment of Mr. Hemang Shah (DIN: 03024324) as an Executive director of the company for a term of 5 (Five) Consecutive years, Subject to approval of the Members of the company at the ensuing 33rd Annual General Meeting of the Company. 5. Appointment of Scrutinizer for scrutinizing the process of E-voting and remote e- voting at 33rd Annual General Meeting of the company; 8hcarat Parenterals Limited Registered Office & Works: Survey No.: 144-A, Jarod-Samlaya Road, Viii. Haripura. Ta. Savli, Dist. Vadodara - 391520 (Guj.) India. Mobile : 99099 28332 E-mail: info@bplindia.in, Web.: www.bplindia.in CIN NO:* L 24231 GJ 1992PLC018237 (WHO-GMP CERTIFIED STAR EXPORT HOUSE) The meeting of Board of Directors commenced at 05:00 p.m. and concluded at 05:30 p.m. We are enclosing herewith the financial results for your information and record. The same will be made available on the Company's website at www.bplindia.in Request you to please take the same on record. Thanking You, FOR BHARAT PARENTERALS LIMITED, Mr. Sharmin Soni Company Secretary & Compliance Officer ICSI Membership No: A-75694 CA (-) : GF, 1" & 2"d Floor, Prasanna House, Associated Society, Opp. Radhakrishna Park, Nr. Akota Stadium Akota, Vadodara - 390020 ' • IND I A '-' : 02~5-3599941I23310608 : +91-91732-02343 / +91-63552-89986 off1ce@smb-ca.com@ : www.smb-ca.com CHARTERED ACCOUNTANTS Independent Auditor's Review Report on Quarterly Unaudited Standalone Financial Results of Bharat Parenterals Limited pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements)R egulations, 2015, as amended. The Board of Directors Bharat ParenteralsL imited . 1. We have reviewed the accompanying statement of unaudited standalone financial results (the Statement') of Bharat Parenterals Limited ('the Company') for the quarter ended on 30th June , 2026 ("the statement") attached being submitted by the Company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. (the "Listing Regulations"). 2. The preparation of the Statement in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34, (Ind AS 34) "Interim Financial Reporting" prescribed under Section 133 of the Companies Act, 2013, as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India, read with the Circular is the responsibility of the Company's management and has been approved by the Board of Directors of the Company, our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the statement in accordance with Standards on Review Engagement (SRE) 2410 "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review is limited primarily to inquiries of company personnel and analytical procedures applied to financial data and thus provide less assurance than an audit. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under section 143( 10) of the Companies Act, 2013 and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. In our opinion and to the best of our information and according to the explanations given to us, the Statement a) Based on our review conduct above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standards ('Ind AS') specified under Section 133 of the Companies Act, 2013 as amended, read with relevant rules issued thereunder recognised accounting practices and policies has not disclosed the information required Page 1 of 2 Shah Mehta & Bakshi Chartered Accountants to be disclosed in terms of the Regulation, read with the Circular, including the manner in which it is to be disclosed, or that it contains any material misstatement. For Shah Mehta & Bakshi Yadodara, August 5, 2026 Page 2 of 2 BHARAT PARENTERALS LIMITED Regd. Office : Viii Haripura, TA Savli, District: Vadodara - 391 520 CIN:L2423 I GJ I 992PLCO 18237 Website: www.bplindia.in STATEMENT OF UNAUDITED STANDALONE FJNANCJAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2026 Rs. In Lakhs Quarter Ended Year Ended Particular 30.06.2026 31.03.2026 30.06.2025 31.03.2026 (Unaudited) {Audited) (Unaudited) {Audited) I A. Revenue from operations 5,550.10 5,653.71 9,436.89 23,401.48 B. Other Income 105.30 444.41 162.04 I 255.23 Total income 5,655.40 6,098.12 9,598.93 24,656.71 2 Expenses A. Cost of materials consumed 3,269.39 4,197.45 5,482.87 14,889.94 B. Purchase of Stock-in-Trade 103.95 68.88 - 100.14 C. Changes in inventories of finished goods, work-in-progress and (31 03) (197.71) 800.45 205.47 stock-in-trade D. Employee benefit expense • 648.01 614.39 596.08 2,513.13 E. Finance costs 69.33 51.47 141.73 343.51 F. Depreciation, depletion and amortisation expense 225.50 203.78 205.82 836.45 G. Other Exoenses 877.20 967.27 1,032.02 3,583.81 Total expenses 5,162.35 5 905.52 8 258.98 22 472.44 3 Total profit before tax 493.05 192.61 1,339.95 2,184.27 4 Tax expense Current tax 156.55 92.22 370.44 660.35 Deferred tax (29.21) (44.16) (30.44) (113.44) Short I (Excess) provision of tax in respect of earlier years - 6.86 - 35.45 Total tax expenses 127.34 54.93 340.00 582.37 s Net Profit I (loss) for period 365.71 137.68 999.95 I 601.90 6 Other comprehensive Income Items that will not be reclassified to profit or loss Remeasurement of defined benefit obligation 6.23 8.26 (4.64) 24.93 Income tax relating to Remeasurement of Defined benefit plans ( 1.57) (2.08) 1.17 (6.28) Other comprehensive Income for the year net of taxes 4.66 6.18 (3.48) 18.66 7 Total Comprehensive Income for the period 370.37 143.86 996.48 I 620.55 8 Paid up Equity Share Capital (Face Value of Rs 10/- per share) 689.20 9 Other Equity 39,545.JO 10 Earnings per share (not annualised, except for March 31, year ended amount) Basic (Rs.) 5.31 2.00 14.51 23.24 Diluted <Rs.) 5.31 2.00 14.51 23.24 See accompanying notes lo the standalone Financia [Showing first 8,000 characters — download PDF for full document]